22nd Century Group Acquires RX Pharmatech Ltd

Grant Avenue Capital Acquires 21st Century Healthcare

January 21, 2026

Food & Beverage

Grant Avenue Capital has acquired 21st Century Healthcare, a Tempe, Arizona-based manufacturer of vitamins, minerals and supplements for humans and pets. Grant Avenue will partner with CEO Kirk Neal and the existing management team to expand 21st Century's product portfolio, scale manufacturing and broaden retail and e-commerce distribution.

Pfizer Acquires Biohaven Pharmaceutical Holding Company Ltd.

October 3, 2022

Pharmaceuticals

Pfizer Inc. completed the acquisition of Biohaven Pharmaceutical Holding Company Ltd. for approximately $11.6 billion (at $148.50 per share), bringing the migraine therapy NURTEC ODT (rimegepant), the zavegepant NDA program, and a CGRP-focused pipeline into Pfizer's Internal Medicine portfolio. Prior to closing, Biohaven spun off its non-CGRP assets into a separate publicly traded company, Biohaven Ltd., which Pfizer received a small pro rata stake in.

GenCanna Acquires CBD Capital Ltd

September 1, 2021

Manufacturing

GenCanna, a Kentucky-based vertically integrated CBD manufacturer, has acquired London-based CBD Capital Ltd to expand its bulk ingredient and finished-goods operations across the United Kingdom, the European Union and other global markets. The deal broadens GenCanna’s formulation and distribution capabilities in Europe; CBD Capital CEO Hassan Akhtar will remain in his role.

Cannabinoid Biosciences Acquires CannabidiolHemp

November 25, 2019

Consumer Products

Cannabinoid Biosciences, Inc., a California-based biopharmaceutical subsidiary of Kid Castle, has acquired CannabidiolHemp (CannabidiolHemp.net), a CBD quality aggregator and validator. The purchase is the first of multiple planned acquisitions intended to build a vertically integrated CBD distribution and supply-chain business across the United States and Canada.

Actylis Acquires Pharm-Rx

October 7, 2024

Pharmaceuticals

Actylis has acquired Pharm-Rx, a Saddle Brook, New Jersey-based supplier of specialty ingredients for the vitamin, mineral and supplement (VMS), OTC and pharmaceutical markets. The deal expands Actylis' nutrition and OTC capabilities and supplier partnerships; Pharm-Rx will continue to operate under its brand and Mark Bostel will become President, Global Nutrition and OTC for Actylis. Financial terms were not disclosed.

Partners Group Acquires Pharmathen from BC Partners

July 19, 2021

Pharmaceuticals

Partners Group has agreed to acquire Pharmathen, the leading European drug delivery technology and pharmaceutical manufacturing company, from BC Partners in a transaction valued at approximately EUR 1.6 billion. The deal transfers control of Pharmathen to Partners Group (acting on behalf of its clients) and is aimed at supporting the company’s continued growth — including an intensified push into the US market — building on strong R&D and manufacturing capabilities.